a randomised double-blind prospective placebo-controlled study
Recent studies suggest that proton pump inhibitor treatment may increase insulin secretion and improve glucose metabolism in type 2 diabetes. In a randomised double-blind prospective placebo-controlled 2 × 2 factorial study, we examined the effect of esomeprazole on insulin secretion, HbA(1c) and cardiovascular risk factors in type 2 diabetes.
Diabetologia, 2013, Vol 56, Issue 1, p. 22-30
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't